Leukemia, Erythroblastic, Acute - 25 Studies Found
Recruiting |
: Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR :
: 2015-02-19 : |
Withdrawn |
: Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission :
|
Completed |
: Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing : Acute Myeloid Leukemia : 2016-07-08 : Other: DNA sequencing |
Withdrawn |
: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia :
|
Terminated |
: Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer : Breast Cancer : 2008-10-21 :
|
Completed |
: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia :
|
Active, not recruiting |
: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Completed |
: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies :
|